NCT04047862 2025-08-22
Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors
BeiGene
Phase 1 Completed
Clinical Trials
22 trialsNCT00483366 2024-09-23
Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors
University of Nebraska
Phase 1 Completed
NCT02715531 2021-07-09
A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors
Hoffmann-La Roche
Phase 1 Completed
NCT00052273 2020-08-03
LY317615 Plus Capecitabine in Treating Patients With Advanced Solid Tumors
Jonsson Comprehensive Cancer Center
Phase 1 Completed
NCT01128842 2018-12-19
A Study Of Neratinib (HKI-272) And Capecitabine In Japanese With Solid Tumor
Puma Biotechnology, Inc.
Phase 1 Completed
NCT00215501 2018-11-02
Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies
Dana-Farber Cancer Institute
Phase 1 Completed
NCT02648425 2018-10-25
Safety and Tolerability of ASLAN001 in Combination With Cisplatin and 5-FU or Cisplatin and Capecitabine
ASLAN Pharmaceuticals
Phase 1 Completed
NCT00004183 2016-07-14
Capecitabine in Treating Patients With Malignant Mesothelioma
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT02494596 2015-11-10
A Phase Ib, Open-label, Multicenter Study of the Safety and PK of the Combination of rhuMAb2c4 (Omnitarg), a Recombinant Humanized Antibody to HER2, and Capecitabine (Xeloda) in Patients With Advanced Solid Tumors
Hoffmann-La Roche
Phase 1 Completed
NCT00547547 2015-11-06
High-Selenium Brassica Juncea, Irinotecan, and Capecitabine in Treating Patients With Advanced Cancer
City of Hope Medical Center
Phase 1 Completed
NCT00121277 2015-07-23
Vorinostat and Capecitabine in Treating Patients With Metastatic or Unresectable Solid Tumors
University Health Network, Toronto
Phase 1 Completed
NCT00005839 2015-06-08
Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor
City of Hope Medical Center
Phase 1 Completed
NCT01463982 2015-04-23
Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies
Hanmi Pharmaceutical Company Limited
Phase 1 Completed
NCT01050985 2014-02-13
A Study of Temsirolimus Plus Capecitabine in Patients With Advanced Cancer
Georgetown University
Phase 1 Completed
NCT00043121 2013-12-11
Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By Surgery
National Cancer Institute (NCI)
Phase 1 Completed
NCT00074321 2013-06-06
Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00253565 2013-04-08
Imatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid Tumors
Duke University
Phase 1 Completed
NCT00039390 2013-01-25
Gefitinib and Capecitabine in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00697502 2012-11-01
Study of Capecitabine In Patients With Solid Tumors
National University Hospital, Singapore
Phase 1 Completed
NCT00077077 2012-05-16
DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Daiichi Sankyo
Phase 1 Completed
NCT00006465 2010-06-11
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Case Comprehensive Cancer Center
Phase 1 Completed
NCT00119171 2008-10-16
Ispinesib In Combination With Capecitabine In Patients With Solid Tumors
GlaxoSmithKline
Phase 1 Completed